Ana Andreazza

Current: Professor, Departments of Pharmacology and Psychiatry; Canada Research Chair in Molecular Pharmacology of Mood Disorders; Thomas C. Zachos Chair in Mitochondrial Research; Scientific Director, Mitochondrial Innovation Initiative
Past: Independent Scientist, Centre for Addiction and Mental Health Toronto, Canada Postdoctoral Fellow, University of British Columbia, Vancouver, Canada

Dr. Ana Andreazza is a Professor in the Departments of Pharmacology & Toxicology and Psychiatry at the University of Toronto. She holds a Tier II Canada Research Chair in Molecular Pharmacology of Mood Disorders and the Thomas C. Zachos Chair in Mitochondrial Research. She is also the Founder and Scientific Director of the Mitochondrial Innovation Initiative (Mito2i), a University of Toronto–based strategic research hub dedicated to advancing mitochondrial science and clinical translation.

Her research program focuses on the role of mitochondrial dysfunction in health and disease, with emphasis on three areas: (1) understanding mitochondrial impairments in neurological and psychiatric disorders such as bipolar disorder and schizophrenia, using innovative models including patient-derived brain organoids; (2) improving mitochondrial health to enhance the success of organ transplantation, with applications in lung and heart preservation; and (3) pioneering mitochondrial transplantation and novel therapeutic strategies, including the development of biomaterials and mitochondrial donor cells for regenerative medicine.

Dr. Andreazza is internationally recognized as a leader in mitochondrial research and biological psychiatry. She is a Senior Fellow of Massey College, a Member of the Royal Society of Canada College of New Scholars, and serves on international scientific boards, including the Bipolar Scientific Steering Committee for BD² and the Institute for Personalized Therapeutic Nutrition.

Awards

  • Sept 2023 Appointed as Senior Fellow of the Massey College
  • Sept 2021 Member of the Royal Society of Canada College of New Scholars
  • Jul 2018 Canada Top 40 Under 40 Award – The top leaders in Canada
  • Jun 2022 Renew CRC- Tier 2 – Canada Research Chair in Molecular Pharmacology of Mood Disorders
  • Jun 2016 CRC- Tier 2 – Canada Research Chair in Molecular Pharmacology of Mood Disorders
  • Dec 2013 Travel Award, American College of Neuropsychopharmacology (ACNP)
  • May 2011 Top Cited Article Neuroscience Letters, time period 2006-2010
  • May 2010 promising young investigator Travel Fellowship Award 2010, Society of Biological Psychiatry
  • Jun 2009 Samuel Gershon Award for Junior Investigator, International Society of Bipolar Disorder (ISBD)
  • Jun 2009 Lilly Young Investigator Fellowship in Bipolar Disorder, 8th International Conference of Bipolar Disorder

Number of Publications

211

More experts